International Edition
Latest News
Health

Common Medications Like Paracetamol and Corticosteroids Can Worsen Fatty Liver, Specialists Warn

"Siempre hay que investigar si se están tomando y, cuando sea factible, retirarlos," said Isabel Graupera Garcia-Milà, a hepatologist at Hospital Clínic de Barcelona. Specialists at the hospital’s hepatology service and the MSD Manual warn that widely used…

Common Medications Like Paracetamol and Corticosteroids Can Worsen Fatty Liver, Specialists Warn

"Siempre hay que investigar si se están tomando y, cuando sea factible, retirarlos," said Isabel Graupera Garcia-Milà, a hepatologist at Hospital Clínic de Barcelona.

Specialists at the hospital’s hepatology service and the MSD Manual warn that widely used medications — including paracetamol, corticosteroids, certain antiepileptics, and some antibiotics — can cause fat buildup in the liver or worsen existing damage, even in people without traditional risk factors such as obesity or diabetes. The risk depends on dose, treatment duration, and whether the patient takes other hepatotoxic drugs or consumes alcohol.

Paracetamol, also known as acetaminophen, is metabolized almost entirely in the liver. When intake exceeds the organ’s capacity to neutralize the toxic byproduct NAPQI with the antioxidant glutathione, cell damage and acute liver failure can result. The maximum recommended adult dose is 4,000 milligrams per day. The MSD Manual classifies paracetamol and nonsteroidal anti-inflammatory drugs as the analgesic group with the highest potential for drug-induced liver injury.

Doctors Graupera Garcia-Milà, Pere Ginès Gibert, and nurse Marta Cervera Carbonell of the Clínic identified specific drug classes linked to secondary non-alcoholic fatty liver disease, according to infobae.

These include corticosteroids, which alter lipid and carbohydrate metabolism; synthetic estrogens in oral contraceptives; antiretrovirals that cause mitochondrial toxicity; tamoxifene used in breast cancer; amiodarone, an antiarrhythmic that accumulates in the liver; methotrexate, used for cancer and autoimmune diseases; and tetracycline antibiotics.

The MSD Manual expands the list to antiepileptics such as carbamazepine, phenobarbital, phenytoin, and valproate; antidepressants including bupropion, fluoxetine, and sertraline; antihypertensives like captopril, enalapril, and losartan; and antibiotics such as amoxicillin-clavulanic acid, clindamycin, and erythromycin.

The Clínic team emphasized that prescribing these drugs does not inevitably lead to cirrhosis. “No quiere decir que el consumo de estos medicamentos lleve de forma inevitable a la cirrosis, pero pueden agravar el daño hepático,” the specialists said. They recommend periodic medication review, liver function monitoring through blood tests and imaging, and a careful benefit-risk assessment when a drug cannot be stopped.

Drug-induced fatty liver is often asymptomatic, allowing fibrosis to progress undetected. “El seguimiento del hígado graso y el control de fibrosis es clave en estos pacientes,” Cervera Carbonell said. A review in the Journal of Clinical and Translational Hepatology notes that obesity, diabetes, pre-existing liver disease, and genetic differences increase vulnerability.

Statins represent an exception. A narrative review in MDPI and the MSD Manual both indicate that statins can be beneficial for steatohepatitis, fibrosis, and hepatocellular carcinoma in patients with metabolic dysfunction-associated steatotic liver disease and do not pose additional risk compared with people without liver disease.

The Clínic advises patients not to stop any prescribed treatment on their own but to consult a hepatology service to evaluate alternatives and establish an individualized monitoring plan. “Si no es factible retirar el medicamento porque el beneficio de tomarlo es superior al perjuicio, hay que hacer seguimiento del hígado graso y controlar si aparece fibrosis,” the specialists concluded.

Drugs flagged for potential liver fat accumulation or toxicity

Drug class Examples cited by Hospital Clínic de Barcelona Additional examples cited by MSD Manual
Analgesics Paracetamol (acetaminophen) NSAIDs
Corticosteroids — —
Hormonal agents Synthetic estrogens (oral contraceptives) —
Antiretrovirals — —
Cancer / immunomodulatory Tamoxifene, Methotrexate —
Antiarrhythmics Amiodarone —
Antibiotics Tetracyclines Amoxicillin-clavulanic acid, Clindamycin, Erythromycin
Antiepileptics — Carbamazepine, Phenobarbital, Phenytoin, Valproate
Antidepressants — Bupropion, Fluoxetine, Sertraline
Antihypertensives — Captopril, Enalapril, Losartan

Paracetamol Dose Limits and Statin Safety in Liver Disease

Paracetamol is not automatically contraindicated, but the maximum daily dose of 4,000 mg must not be exceeded, and it should not be combined with alcohol or other hepatotoxic drugs without medical supervision.

Current evidence reviewed by the MSD Manual and published in MDPI suggests statins are safe and may even benefit patients with metabolic dysfunction-associated steatotic liver disease, including improvements in steatohepatitis and fibrosis.

Hospital Clínic de Barcelona, founded in 1906 and opened on December 22 of that year with 400 beds, serves as the university hospital for the University of Barcelona Faculty of Medicine. It functions as both a community hospital for an assigned population of 540,000 and a tertiary referral center for complex cases across Spain and internationally. In 2020 Newsweek ranked it the best hospital in Spain and among the top 25 worldwide.

No. Specialists at Hospital Clínic de Barcelona advise against stopping any treatment without consulting a hepatology service, which can weigh the drug’s benefits against liver risk and arrange appropriate monitoring.

About the author: Health Desk

Health Desk at Archynewsy.